ASU researchers develop blood test that can help predict cancer prognosis
Working with the Virginia G. Piper Center for Personalized Diagnostics, ASU researchers are trying to improve the survival rates of people with pancreatic cancer. A team led by Tony Wu, a Fulton Schools professor of biomedical engineering, is contributing to those efforts by developing new methods of detecting hypoxia in pancreatic cancer patients. Hypoxia is a condition that deprives tumor tissue of adequate oxygen. The higher the level of hypoxia, the more difficult it is to treat cancerous tumors.